Benign neoplasms of the genitourinary system (DC 7529)
DC 7529 covers benign tumors and masses of the genitourinary system — kidney (renal cell adenoma, angiomyolipoma), bladder (papilloma), prostate (excluded as BPH is rated under DC 7527), urethra, ureter, and other benign GU growths. These can produce obstruction, infection, kidney damage, or urinary symptoms depending on location and size. The VA does not maintain a separate ladder for benign GU neoplasms. Instead, 38 CFR § 4.115a directs raters to evaluate this condition under whichever ladder produces the higher result when applied to the predominant residual symptom: voiding dysfunction (0-60%, three sub-formulas) when urinary symptoms dominate, or renal dysfunction (0/30/60/80/100%) when kidney function damage dominates.
Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.